Thompson Medical v. Ciba-Geigy
In a complaint filed in the New York Federal Court June 27, Thompson charged that Ciba-Geigy ads falsely claim Acutrim lasts four hours longer than any other diet pill and is more effective in aiding weight loss than Thompson's Dexatrim. Thompson is seeking an injunction to prevent airing of the ads. which have appeared on television since November, and unspecified compensatory and punitive damages
You may also be interested in...
Use of per- and polyfluoroalkyl substances in cosmetic products appears to be declining, based on voluntary industry registrations with the US Food and Drug Administration. In any event, NGOs are gunning for PFAS' elimination, and the FDA says available data have yet to give a complete safety picture for PFAS used intentionally in cosmetics or present as impurities.
Exec Chat: How Edwards Lifesciences Deploys AI, Remote Monitoring To Help Doctors Make Life-Critical Decisions
Edwards Lifesciences’ head of critical care expects that “smart recovery” AI-driven products will grow the fastest in its critical care unit, which is expected to reach $800m in total revenues for 2021.
I.V. Korsuva now has an August FDA action date, which partner Vifor would commercialize in the ESRD dialysis setting while Cara works toward a broad anti-pruritus label for its oral tablet formulation.